Base to Base biotech podcast 68: Water from air for pharma and beyond
New phase 1 data show potential for neurodegenerative disease treatment
Metabolic syndrome linked to faster brain ageing
Bowel cancer samples could boost understanding of other killer diseases
Study identifies which patients benefit most from new schizophrenia drug
Mechanism behind overactive immune cells revealed
Investigational treatment of autosomal dominant polycystic kidney disease receives orphan drug designation
World’s first gene-editing therapy for hyperlipidemia
Positive results for Lilly obesity drug
“Foundational moment for in vivo cell therapy”
Cooperative motor proteins kill cancer cells when dual-inhibited
SanegeneBio announces collaboration with Lilly